Over a decade ago, Malik Y. Kahook, MD, spotted a problem: The adherence rate of glaucoma patients using eye-drop medication to treat their condition was an abysmal 50%. He wondered if the drug could be delivered from inside the eye without the patient having to do anything.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Elevation Diagnostics addresses the growing demand for fast, accurate diagnostic testing in our community. With our flagship location at Fitzsimons Innovation Community, we are committed to providing continuing high-quality testing to meet the needs of […]
Lia Gore, MD, is a pediatric oncologist who specializes in blood cancers. She has led clinical trials on the CU Anschutz Medical Campus resulting in FDA approval of five cancer drugs that have saved and […]
Following federal efforts like the drug price reforms in the Inflation Reduction Act, some states have also taken it into their own hands to curb the prices of drugs. On Friday, Colorado’s Prescription Drug Affordability […]
Copyright © 2026 Biotech Networks
